A first-of-its-kind Maryland law permitting the state’s attorney general to sue pharmaceutical companies that substantially raise generic drug prices was ruled unconstitutional by a three-judge panel from the 4th U.S. Circuit Court of Appeals in Association for Accessible Medicines v. Frosh (887 F.3d 664). The law was passed in April 2017 with bipartisan support as …
